What is Washington Square Endodontics?
Washington Square Endodontics operates as a premier provider of specialized dental care, focusing on complex procedures such as root canal therapy, endodontic retreatment, and the management of traumatic dental injuries. Under the clinical leadership of Drs. Wiltbank and Reese, the practice has cultivated a reputation for excellence, bridging the gap between referring general dentists and patients requiring high-acuity intervention. By prioritizing a compassionate patient experience alongside technical precision, the firm maintains a competitive advantage in the healthcare services market, ensuring that complex endodontic needs are met with consistent, high-quality outcomes.
How much funding has Washington Square Endodontics raised?
Washington Square Endodontics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Washington Square Endodontics
PPP
Public-Private Partnership
What's next for Washington Square Endodontics?
The infusion of capital is expected to catalyze the next phase of growth for Washington Square Endodontics, likely focusing on the expansion of clinical capacity and the integration of cutting-edge diagnostic technologies. As the practice navigates this late-stage development, the strategic deployment of these funds will be critical in enhancing operational efficiencies and strengthening the referral network. By leveraging this financial backing, the organization is well-positioned to maintain its standard of care while potentially exploring new service modalities or facility upgrades that align with the evolving demands of the endodontic landscape.
See full Washington Square Endodontics company page
